Navigation Links
Femasys Receives FDA 510(k) Clearance for First Low Pressure HSG Device

ATLANTA, Nov. 7, 2011 /PRNewswire/ -- Femasys Inc., an emerging medical device developer of women's healthcare solutions, announced today that it has received 510(k) clearance for the FemChec™ Pressure Management Device, the first device designed for a low pressure HSG as a confirmation test after a permanent sterilization procedure is performed.  FemChec utilizes patent-pending technology that limits the applied intrauterine pressure to 200 mmHg, providing confidence to the physician that he/she will not overpressurize while adequately filling the uterine cavity and cornu to obtain the required images.  FemChec allows the physician to meet the requirements of the mandatory HSG confirmation test and may reduce improperly performed tests and procedure complications.


Kathy Lee-Sepsick, Femasys' President & CEO, commented, "We have utilized our expertise to respond to the market need for a low pressure HSG test that can be performed with confidence, taking the guesswork out of whether low pressure is truly achieved.  The FemChec provides clear benefits to the physician and ultimately the patient as a properly performed low pressure confirmation test is critical to relying on the permanent sterilization procedure long-term."

The FemChec Pressure Management Device will be presented to the gynecologic community in November at the AAGL meeting in Hollywood, Florida.  Femasys expects the first devices to begin shipping in the U.S. market in December and is pursuing strategic corporate partnerships for FemChec.  The product is expected to contribute to the growing revenue base of Femasys branded products.  Earlier this year, Femasys launched the FemVue Saline-Air Device designed to provide gynecologists and their patients with a simple way to evaluate tubal patency in the office with existing ultrasound.  The FemVue product has been very well received and is being distributed in the U.S. by Norgenix.  The Company is actively seeking other distribution partners for the rest of the world.

About FemasysFemasys is a privately held corporation committed to advancing women's healthcare with innovative medical devices.  The company is continually researching and developing cost-effective new products designed for women, often expanding in-office services that physicians can easily incorporate.

Please visit and for additional information.

For more information contact:Steve Damon

Jerry FinkBusiness Development

jfink@femasys.com770.500.3910 (office)

770-500.3910 (office)770.598.6446 (mobile)

SOURCE Femasys Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Femasys and Norgenix Announce Distribution Agreement for Groundbreaking New Device for Infertility Diagnosis
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. CryoCor Receives FDA Approval for Right Atrial Flutter
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
Post Your Comments:
(Date:5/30/2020)... WASHINGTON (PRWEB) , ... May 29, 2020 , ... ... the following statement in response to the U.S. announcement that it will terminate ... with the Administration’s announcement that it plans to terminate its relationship with the ...
(Date:5/30/2020)... ... 30, 2020 , ... During a crisis, the platitude “stay strong” is well-intended, ... is developed and strengthened through hardship. Recent research conducted by reveals ... practices in order to stay strong in the face of adversity. It seems that ...
(Date:5/28/2020)... ... May 28, 2020 , ... When Sean Fitzgerald was in business ... able to help provide the physical care services needed to keep older adults in ... houses themselves. Now Fitzgerald is pleased to be in a position to help provide ...
Breaking Medicine Technology:
(Date:5/27/2020)... Ore. (PRWEB) , ... May ... ... May 2020 , Guest: Dr. Gerald Pollack, University of Washington Professor of ... Phase of Water: Beyond Solid, Liquid & Vapor ( ) , ...
(Date:5/26/2020)... ... May 26, 2020 , ... ... leading RevSpring solutions—Talksoft® patient messaging and IVR Advantage™--for Loyale customers. Talksoft pre-service ... automated and precise texts, IVR reminders and email messages tailored to each ...
(Date:5/26/2020)... ... May 26, 2020 , ... Sex educator, activist, humanitarian, and Wicked Pictures star ... just received the 2020 AASECT Audio Visual Award for jessica drake's Guide to Wicked ... its kind to feature non-actors in its demonstrations and narratives and was produced and ...
(Date:5/25/2020)... ... May 23, 2020 , ... Winemaker Grant Long Jr. is introducing ... present something whimsical and delicious in these complicated times,” he said, in announcing the ... 2018 Grenache ($24.99). The Chardonnay and Red Wine Blend are sourced in the Napa ...
(Date:5/21/2020)... ... ... In response to the Coronavirus pandemic, Industrial Magnetics, Inc.(IMI) has developed the ... without using their hands or fingertips. , The new Arm-Pull attaches to ... wrist or elbow when entering or exiting a room. , Perfect for public restrooms, ...
Breaking Medicine News(10 mins):